PERRIGO COMPANY PLC |
Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
| 29,94 USD | -0,33 % |
|
-4,28 % | -6,96 % |
| 08.04. | PERRIGO COMPANY PLC : erhält Kaufen-Rating von Piper Sandler | ZM |
| 04.04. | CVS Caremark übernimmt die Antibabypille von Perrigo in den USA zum Nulltarif für Kostenträger | RE |
Kurzporträt
Mitarbeiterzahl: 9 140
Umsatz nach Geschäftsbereich
| USD in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
|---|---|---|---|---|---|
Consumer Self-Care Americas
63,6
%
| 2 926 | 65,7 % | 2 962 | 63,6 % | +1,24 % |
Consumer Self-Care International
36,4
%
| 1 526 | 34,3 % | 1 693 | 36,4 % | +10,99 % |
Umsatz je Region
| USD in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
|---|---|---|---|---|---|
United States
62,7
%
| 2 870 | 64,5 % | 2 917 | 62,7 % | +1,63 % |
Europe
34,0
%
| 1 445 | 32,5 % | 1 582 | 34,0 % | +9,46 % |
All Other Countries
2,5
%
| 107 | 2,4 % | 116 | 2,5 % | +8,39 % |
Ireland
0,9
%
| 29 | 0,7 % | 41 | 0,9 % | +39,25 % |
Manager
| Manager | Titel | Alter | Seit |
|---|---|---|---|
| Chief Executive Officer | 55 | 30.06.23 | |
Eduardo Bezerra
DFI | Director of Finance/CFO | 49 | 16.05.22 |
Alison Ives
CTO | Chief Tech/Sci/R&D Officer | - | 01.01.15 |
Ronald Janish
COO | Chief Operating Officer | 58 | 01.01.03 |
Grainne Quinn
CTO | Chief Tech/Sci/R&D Officer | 54 | 01.01.14 |
| Chief Tech/Sci/R&D Officer | 66 | 01.10.06 | |
Bradley Joseph
IRC | Investor Relations Contact | - | - |
Adrian Innergård
PRN | Corporate Officer/Principal | 44 | - |
| Corporate Officer/Principal | 55 | 11.09.23 | |
Robert Willis
HRO | Human Resources Officer | 55 | 01.05.13 |
Aufsichtsräte
| Aufsichtsräte | Titel | Alter | Seit |
|---|---|---|---|
Orlando Ashford
CHM | Chairman | 55 | 15.12.20 |
Jeffrey Kindler
BRD | Director/Board Member | 68 | 06.02.17 |
Bradley Alford
BRD | Director/Board Member | 67 | 06.02.17 |
Donal O'Connor
BRD | Director/Board Member | 73 | 01.11.14 |
Geoffrey Parker
BRD | Director/Board Member | 59 | 07.11.16 |
Erica L. Mann
BRD | Director/Board Member | 65 | 26.04.19 |
| Director/Board Member | 61 | 02.05.17 | |
Katherine Doyle
BRD | Director/Board Member | 56 | 29.07.20 |
Julia Brown
BRD | Director/Board Member | 54 | 01.11. |
| Director/Board Member | 60 | 30.07.22 |
Anteilsklasse
| Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
|---|---|---|---|---|---|
| Aktie A | 1 | 135 515 939 | 135 095 417 ( 99,69 %) | 0 | 99,69 % |
Unternehmenskontakt
Konzerngesellschaften
| Name | Kategorie und Branche |
|---|---|
Perrigo Israel Pharmaceuticals Ltd.
 Perrigo Israel Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Perrigo Israel Pharmaceuticals Ltd. develops and markets generic products, pharmaceutical ingredients, novel dermatological products, and consumer products. The firm operates manufacturing facilities in the United States, Israel, United Kingdom, Mexico, and Germany. The company was founded in 1983 and is headquartered in Bnei Braq, Israel |
Pharmaceuticals: Major
|
Pharmaceuticals: Major
| |
Rosemont Pharmaceuticals Ltd.
 Rosemont Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Rosemont Pharmaceuticals Ltd. develops, manufactures, and supplies oral liquid medicines. Its product categories include anaesthesia, cardiovascular system, central nervous system, endocrine system, gastro-intestinal system, infections malignant disease and immunosuppression, musculoskeletal and joint disease, nutrition and blood, and PEG/NG tube administration guides. The company was founded in 1967 and is headquartered in Leeds, the United Kingdom. |
Pharmaceuticals: Major
|
Wrafton Laboratories Ltd.
 Wrafton Laboratories Ltd. Pharmaceuticals: OtherHealth Technology Wrafton Laboratories Ltd. manufactures pharmaceutical products. It supplies medicines, vitamin supplements, herbal medicines and medical devices to the supermarket chains. Wrafton Laboratories Ltd. is a subsidiary of Perrigo Co. The company was founded in 1992 and is headquartered in Braunton, UK |
Pharmaceuticals: Other
|
Elan Finance Plc
|
Finance/Rental/Leasing
|
Omega Pharma Capital NV
 Omega Pharma Capital NV Financial ConglomeratesFinance Part of Perrigo Co. Plc, Perrigo Capital NV is a company that focuses on encouraging Belgian patients to take proactive control of their health in partnership with pharmacists as central care providers. The private company is based in Nazareth, Belgium. The company is brand builders at Perrigo Belgium, placing the Belgian patient at the center of everything they do and creating demand by addressing the patient's needs in a relevant and engaging manner. The company aims to make lives better by bringing quality, affordable self-care products that consumers trust wherever they are sold. The company was founded in 1987, and the CEO is Barbara de Saedeleer. |
Financial Conglomerates
|
Omega Pharma Belgium NV
 Omega Pharma Belgium NV Medical DistributorsDistribution Services Part of Perrigo Co. Plc, Omega Pharma Belgium NV is a Belgian pharmaceutical company that supplies pharmaceuticals. The private company is based in Nazareth, Belgium. The company was founded in 1977. Christophe van Damme has been the CEO of the company since 2020. |
Medical Distributors
|
Galpharm International Ltd.
 Galpharm International Ltd. Pharmaceuticals: MajorHealth Technology Galpharm International Ltd. manufactures and supplies over-the-counter and branded medicines. The company was founded on February 24, 1981 and is headquartered in Braunton, the United Kingdom. |
Pharmaceuticals: Major
|
Perrigo UK Acquisition Ltd.
 Perrigo UK Acquisition Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Perrigo Co. Plc, Perrigo UK Acquisition Ltd. provides business support services. The private company is based in Braunton, UK. |
Miscellaneous Commercial Services
|
Sektor
Umsatz nach Geschäftsbereich
Umsatz je Region
Verlauf des Gewinns je Aktie
| % 1. Jan. | Kap. | |
|---|---|---|
| -6,96 % | 4,06 Mrd. | |
| +27,97 % | 672 Mrd. | |
| +23,79 % | 550 Mrd. | |
| -7,02 % | 351 Mrd. | |
| +14,85 % | 317 Mrd. | |
| +6,25 % | 292 Mrd. | |
| +2,15 % | 211 Mrd. | |
| -0,40 % | 203 Mrd. | |
| -10,10 % | 194 Mrd. | |
| -11,81 % | 144 Mrd. |
- Börse
- Aktien
- A1XAEY Aktie
- Unternehmen Perrigo Company plc
